| Literature DB >> 35114102 |
Xiaofeng Gu1, Jeffrey Richman1, Peter Langfelder1, Nan Wang1, Shasha Zhang1, Monica Bañez-Coronel2, Huei-Bin Wang3, Lucia Yang1, Lalini Ramanathan1, Linna Deng1, Chang Sin Park1, Christopher R Choi1, Jeffrey P Cantle1, Fuying Gao1, Michelle Gray4, Giovanni Coppola1, Gillian P Bates5, Laura P W Ranum2, Steve Horvath6, Christopher S Colwell3, X William Yang7.
Abstract
In Huntington's disease (HD), the uninterrupted CAG repeat length, but not the polyglutamine length, predicts disease onset. However, the underlying pathobiology remains unclear. Here, we developed bacterial artificial chromosome (BAC) transgenic mice expressing human mutant huntingtin (mHTT) with uninterrupted, and somatically unstable, CAG repeats that exhibit progressive disease-related phenotypes. Unlike prior mHTT transgenic models with stable, CAA-interrupted, polyglutamine-encoding repeats, BAC-CAG mice show robust striatum-selective nuclear inclusions and transcriptional dysregulation resembling those in murine huntingtin knockin models and HD patients. Importantly, the striatal transcriptionopathy in HD models is significantly correlated with their uninterrupted CAG repeat length but not polyglutamine length. Finally, among the pathogenic entities originating from mHTT genomic transgenes and only present or enriched in the uninterrupted CAG repeat model, somatic CAG repeat instability and nuclear mHTT aggregation are best correlated with early-onset striatum-selective molecular pathogenesis and locomotor and sleep deficits, while repeat RNA-associated pathologies and repeat-associated non-AUG (RAN) translation may play less selective or late pathogenic roles, respectively.Entities:
Keywords: BAC transgenic; BAC-CAG; BACHD; CAG repeat; HD; Huntingtin; Huntington’s disease; RAN translation; RNA foci; RNA-seq; aggregation; instability; knockin; motor deficits; muscleblind; mutant huntingtin; nuclear inclusions; polyglutamine; striatum; transcriptional dysregulation; transcriptionopathy
Mesh:
Substances:
Year: 2022 PMID: 35114102 PMCID: PMC9462388 DOI: 10.1016/j.neuron.2022.01.006
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 18.688